comparemela.com

Page 15 - முதலீட்டாளர் உறவுகள் அணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza: IDMC recommend early analysis of OlympiA

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza: IDMC recommend early analysis of OlympiA
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

AstraZeneca (LSE:AZN) | RNS | AstraZeneca PLC - Lynparza: IDMC recommend early analysis of OlympiA

AstraZeneca (LSE:AZN) | RNS | AstraZeneca PLC - Lynparza: IDMC recommend early analysis of OlympiA
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: AstraZeneca Non-Executive Board changes

    AstraZeneca PLC announced today that Non-Executive Directors Geneviève Berger and Graham Chipchase intend to retire from the Board at the conclusion of the Company s Annual General Meeting on 30 April 2021. By that date, each will have served on the Board for nine years.   All other Non-Executive Directors will present themselves for election or re-election at the AGM, including Leif Johansson, Non-Executive Chairman, as will Pascal Soriot, Chief Executive Officer and Marc Dunoyer, Chief Financial Officer.    Mr Johansson was first elected to the Board in April 2012 and will have served as a Director for nine years by April 2021. In December 2020, the Company announced it had entered into a definitive agreement with Alexion Pharmaceuticals, Inc. for AstraZeneca to acquire Alexion. Subject to the satisfaction of the closing conditions, which include approval by AstraZeneca and Alexion shareholders and obtaining relevant regulatory clearan

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.